Chemotherapeutic properities of anthramycin.
D000563:Amebicides / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D006224:Cricetinae; D046508:Culture Techniques; D000882:Haplorhini; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D009181:Mycoses / Q000188:drug therapy; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy*; D014777:Virus Diseases / Q000188:drug therapy
D000563:Amebicides; D000871:Anthelmintics; D000903:Antibiotics, Antineoplastic; D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents